Login to Your Account



Insulin stars in POD cast as Oramed encapsulates phase IIb top-line victory

By Randy Osborne
Staff Writer

Wednesday, May 18, 2016

With solid top-line phase IIb data for its oral insulin in hand, "everything is focused on taking this from where we are right now into a phase III trial," Chief Operating Officer Josh Hexter told BioWorld Today.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription